|
|
||||||||
|
FIGURE 4. Baseline and postprocedural MMP-1 levels in patients with target lesion SUVmax > 2 (left) and
2 (right). *P < 0.05.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |